Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
September 2023
in “
Curēus
”
New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
Studysummary This study reported that topical spironolactone improved lid margin vascularity, corneal fluorescein staining, and disease severity scores in patients with ocular graft-versus-host disease, suggesting a potential therapeutic role by enhancing corneal lipid production with minimal adverse effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer